Gyrodyne, LLC (NASDAQ:GYRO – Get Free Report) was the target of a significant drop in short interest in December. As of December 31st, there was short interest totalling 600 shares, a drop of 33.3% from the December 15th total of 900 shares. Based on an average daily volume of 2,400 shares, the short-interest ratio is currently 0.3 days. Approximately 0.0% of the company’s stock are sold short.
Gyrodyne Stock Performance
GYRO opened at $9.06 on Wednesday. The stock has a 50-day moving average price of $9.50 and a 200-day moving average price of $8.78. Gyrodyne has a 1 year low of $7.65 and a 1 year high of $11.96. The company has a quick ratio of 1.78, a current ratio of 1.78 and a debt-to-equity ratio of 0.37.
Insider Buying and Selling at Gyrodyne
In related news, major shareholder Towerview Llc sold 6,654 shares of the company’s stock in a transaction that occurred on Friday, October 18th. The stock was sold at an average price of $11.42, for a total value of $75,988.68. Following the sale, the insider now owns 341,346 shares in the company, valued at $3,898,171.32. This represents a 1.91 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Insiders own 12.10% of the company’s stock.
Institutional Trading of Gyrodyne
About Gyrodyne
Gyrodyne, LLC owns and manages a diversified portfolio of real estate properties comprising office, industrial and service-oriented properties in the New York metropolitan area. Gyrodyne owns a 63 acre site approximately 50 miles east of New York City on the north shore of Long Island, which includes industrial and office buildings and undeveloped property which is the subject of plans to seek value-enhancing entitlements.
Featured Stories
- Five stocks we like better than Gyrodyne
- How Can Investors Benefit From After-Hours Trading
- 3 Dividend Stocks at Bargain Levels to Defend Your Portfolio
- Conference Calls and Individual Investors
- 3 REITs With Big Dividend Growth and Sustainable Payouts
- What Are Some of the Best Large-Cap Stocks to Buy?
- Can Integrated Healthcare Stocks Succeed in Public Markets?
Receive News & Ratings for Gyrodyne Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gyrodyne and related companies with MarketBeat.com's FREE daily email newsletter.